Pharmaceutical Industry

Page 84 of 100

Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health

Valeant Appoints Howard Schiller Interim CEO

By
January 6, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
International

Shire-Baxalta $32 Billion Merger Talks Said to Advance

By
January 3, 2016
US-CRIME-JUSTICE-SHKRELI
Health

Martin Shkreli’s Old Company Has Filed For Bankruptcy

By
December 30, 2015
sb10065848dh-001
Tech

New Research Shows How the Liver Fights off Sugar Cravings

By
December 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership

Valeant Will Be Run by a Group of Executives Until Its CEO Returns

By
December 28, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership

Valeant CEO J. Michael Pearson Hospitalized for ‘Severe’ Pneumonia

By
December 26, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Aftershocks Keep Coming After Former Pharma CEO’s Arrest

By
December 24, 2015
Inside Teva Pharmaceuticals Headquarters
Health

Celgene Settles U.S. Patent Litigation for Revlimid

By Reuters and Aaron Task
December 23, 2015
APTOPIX Shkreli Arrest
Finance

KaloBios Just Fired Martin Shkreli as CEO

By
December 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Martin Shkreli Says This Is the Real Reason He Was Arrested

By
December 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Martin Shkreli’s Twitter Account Hacked

By Reuters and Aaron Task
December 21, 2015
Martin Shkreli arrested
Health

Martin Shkreli’s Arrest Halts Leukemia Drug Trial

By
December 20, 2015
Martin Shkreli Says Securities Fraud Charges Are ‘Baseless’
Leadership

Martin Shkreli Says Securities Fraud Charges Are ‘Baseless’

By
December 20, 2015
Inside of a Gilead Sciences Lab
Finance

Isis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price

By
December 18, 2015
US-CRIME-JUSTICE-SHKRELI
Health

Turing Replaces Martin Shkreli with Interim CEO

By
December 18, 2015

Most Popular